At PartnerRe, we are a community of curious, intelligent industry experts, united by a drive to outperform. As an international reinsurer with a robust capital base, we are a market leader with a reputation of financial stability and strength, and a commitment to rebuilding businesses and communities after risk events around the world.

HarbourVest Partners

PartnerRe

The PartnerRe US Health PULSE + Plus team has the details on the new US Food & Drug Administration (FDA) approval for gene therapy, Casgevy, treating transfusion-dependent beta thalassemia. Find out more: https://lnkd.in/emQ8RdCj #YourReinsurancePartner #genetherapy 

Prajakt Mahajan, Head of Underwriting Services & Solutions-US Life, will be participating in a panel discussion at the 2024 Metropolitan Underwriting Discussion in New York City. Learn more: https://www.mudgroup.org/ #YourReinsurancePartner

PartnerRe announces the retirement of Jacques Bonneau and the appointments of Philippe Meyenhofer as CEO and Jon Colello as President, effective April 1, 2024. With these changes, Christian Mitterer is named CEO Specialty Lines and Ingrid Gjonaj Fisk joins the Executive Leadership team as CEO P&C EMEA. View full release: https://lnkd.in/e6UzM5b2 

Data science is transforming the life insurance industry, generating innovative solutions. At PartnerRe, we not only deliver concrete solutions to our clients, we also empower them to leverage data science effectively within their organization. Discover what's possible when you have a true partner by your side. https://lnkd.in/g7jctj47 #YourReinsurancePartner

PartnerRe Ltd is a Bermuda-based holding company for international reinsurance groups, including Partner Reinsurance Company, Partner Reinsurance Europe SE, Partner Reinsurance Company of the U.S., and Partner Reinsurance Asia. PartnerRe reinsures risks include property, casualty, motor, agriculture, aviation/space, catastrophe, credit/surety, engineering, energy, marine, specialty property, specialty casualty, multiline and other lines, mortality, longevity, accident and health, and alternative risk products. The company operates through the following segments the P&C segment, the Specialty segment under the non-life division, and the Life and Health segment. PartnerRe derives the majority of its revenue from the P&C segment.

COM:PARTNERRE

PartnerRe Ltd.

Last Close

16.75

19/07 22:30

Volume Today

1.57M

Avg: -

Filings Not Available